Cancer is a devastating disease that is affecting millions of people globally. Moreover, it drains patients physically and financially. Recently, India has emerged as a hub for medical tourism and… Continue Reading
Blogs
GST Reduction on Cancer Drugs to Enhance Patient Access
The 54th GST Council meeting, chaired by Finance Minister Nirmala Sitharaman, has approved a reduction in GST rates from 12% to 5% for three cancer drugs: trastuzumab deruxtecan, osimertinib, and… Continue Reading
New Treatment Regimen for Multi-Drug-Resistant TB Approved
The Indian government has approved a new, shorter treatment for multi-drug-resistant tuberculosis (MDR-TB). This new regimen, called BPaLM, combines four drugs: Bedaquiline, Pretomanid, Linezolid, and optionally Moxifloxacin. It can cure… Continue Reading
Lenacapavir: New HIV Drug Could Cut Costs to $40 Annually. Slashing Current Costs by 1,000 Times
Lenacapavir Overview: Manufacturer: Gilead, a US pharmaceutical company. Type: Antiretroviral drug. Administration: Injected twice a year, simplifying treatment compared to daily pills. Effectiveness: 100% effective in preventing HIV infection in… Continue Reading
Victory for TB Patients in India
In a significant win for children suffering from tuberculosis (TB), more affordable versions of a crucial TB drug will soon be available in India. On July 5, the country’s patent… Continue Reading